DGAP-News: bmp Holding AG: Results for the 1st quarter of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DGAP-News: bmp Holding AG: Results for the 1st quarter of 2016

DGAP-News: bmp Holding AG / Key word(s): Quarterly / Interim Statement/Quarter Results bmp Holding AG: Results for the 1st quarter of 2016 31.05.2016 / 11:00 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- bmp Holding AG: Results for the 1st quarter of 2016 - Quarterly revenue of EUR 4.25 million - Consolidated earnings of minus EUR 2.3 million burdened through an individual value adjustment of almost EUR 2 million - Annual forecast for the operative business confirmed bmp Holding AG's (ISIN DE0003304200) revenue developed in line with planning in the first quarter 2016. Consolidated revenue amounted to EUR 4.25 million (prior-year period: EUR 0.0 million). Together, sleepz GmbH and the Matratzen Union Group companies thus generated growth of almost 40% in comparison to their revenue in the first quarter of 2015, when they were not yet included in the scope of consolidation of bmp Holding AG. Grafenfels Manufaktur GmbH did not yet contribute any revenue in the first quarter. The gross profit margin of slightly above 30% was also in line with expectations. Consolidated earnings of minus EUR 2.3 million (prior-year period: EUR 1.05 million) were heavily burdened by a specific valuation allowance of approximately EUR 2 million that was needed for one of the available-for- sale venture capital investments. The company had counted on a financing from former shareholders, which was cancelled at short notice. As a result, this former investment is highly vulnerable to default. The operating subsidiaries sleepz GmbH, Grafenfels Manufaktur GmbH and the companies of the Matratzen Union Group developed in line with planning, with a net loss of EUR 313 thousand. While Grafenfels and sleepz still reported losses, the Matratzen Union Group contributed a positive quarterly result. The holding company itself generated a loss of EUR 142 thousand, which also developed in line with planning. Because the second quarter seasonally tends to be weaker than the first in our sector, we expect to see a slight decrease in quarterly revenue from sleepz as well as of the Matratzen Union Group. At the same time, Grafenfels will make its first contribution to revenue, although this is expected to be small still. Overall, we therefore anticipate revenue of EUR 3.5 million in the second quarter. Acquisitions of additional companies will not take place in the second quarter. In view of the discontinuation of its venture capital business, in May bmp Holding AG rescinded the investment consultancy contract agreed with bmp Beteiligungsmanagement AG with a term from 2011until the end of 2021 by mutual agreement and replaced it with a "contract for the management and sale of the old VC investments" with a significantly shorter term until the end of 2017. The contract provides for quarterly remuneration of EUR 100 thousand from 1 April 2016 to 31 December 2017. The previously accrued carry claim is fully offset against this remuneration totalling EUR 700 thousand. The forecast for the year with organic revenue of EUR 20 million and earnings from ordinary business activities of minus EUR 1 million to minus EUR 2 million still applies. The guidance of revenue of EUR 25 million to EUR 40 million including an additional one or two company acquisitions also remains in place, with the effect on consolidated revenue largely being influenced by the timing of possible acquisitions in the second half of the year. This in turn is dependent on the implementation of successful exits in the coming months. The complete quarterly statement is published under www.bmp-holding.de. For further information: bmp Holding AG Corinna Riewe Schlüterstraße 38 10629 Berlin Tel.: +49 30 2030 5567 criewe@bmp.com This Corporate News is neither an offer nor a request to submit an offer for the sale of securities - specifically not in the US or other countries or jurisdictions in which an offer or request to submit an offer for the purchase or sale would be illegal without prior registration or permission under the relevant securities guidelines. This Corporate News is neither an offer to sell registered bearer shares nor a request to submit an offer to buy the registered shares; it is merely for information purposes. --------------------------------------------------------------------------- 31.05.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: bmp Holding AG Schlüterstraße 38 10629 Berlin Germany Phone: +49 (0)30 20 305-0 Fax: +49 (0)30 20 305-555 E-mail: ir@bmp.com Internet: www.bmp-holding.de ISIN: DE0003304200 WKN: 330420 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart; Warschau End of News DGAP News Service --------------------------------------------------------------------------- 467743 31.05.2016

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 232

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 136

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 104

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 373

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 103

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 0

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 49

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 133

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 38

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 135

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading

Top 5 Most Recently Viewed Articles

Cassava Sciences Takes Strategic Steps Amid Clinical Developments

Updated Category News Views 241

Cassava Sciences Provides Key Business Update Cassava Sciences, Inc. (NASDAQ: SAVA), a biotechnology company dedicated to developing innovative treatments for central nervous system disorders, has shared an important business update that affects both its operations and strategic direction. Important Study Results and Future Plans Recent data from the Phase 3 RETHINK-ALZ...

Continue Reading
ColdVentures Welcomes Dr. Barrak Alahmad as Strategic Advisor

Updated Category News Views 164

ColdVentures Expands Leadership with Key Appointment ColdVentures, a pioneering medical device company focused on addressing heat-related illnesses, has taken a significant step forward by appointing Dr. Barrak Alahmad as a strategic advisor. Dr. Alahmad, known for his expertise in environmental health and climate change, brings a wealth of knowledge to the role,...

Continue Reading
Season Group Hits Top 15% with EcoVadis Silver Medal

Updated Category News Views 40

Season Group's Silver Medal Moment Well, it's not every day that a company gets a pat on the back for actually doing something good, but that's what you have here with Season Group snagging the EcoVadis Silver Medal. It’s like the Oscars for sustainability, and it puts them in the top 15% of companies assessed globally by these sustainability gurus. That’s a title...

Continue Reading
LSPedia Achieves Notable Recognition in Business Category

Updated Category News Views 144

LSPedia Celebrated for Excellence in Business LSPedia is thrilled to announce its recent inclusion in Inc.'s 2024 Best in Business list, specifically in the Software as a Service category. This prestigious recognition highlights organizations that are industry leaders and stand out for their impactful achievements. A Testament to Industry Leadership In recognizing...

Continue Reading
Bev Colan Appointed as President of Venn Workforce Optimization

Updated Category News Views 216

Venn Workforce Optimization Welcomes New Leadership In an exciting development for Venn Workforce Optimization, Bev Colan has been named the company president. This marks a significant step for the organization, which specializes in locum tenens optimization and workforce solutions technology. Bev Colan: A Proven Leader Bev Colan joins the Venn team with over 20 years of...

Continue Reading